pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    NovoCardia
    Congestive Heart Failure (Heart Failure) Help Therapeutics
  • Phase 2
    Nu-3
    Diabetic Foot Ulcers Lakewood-Amedex Inc
  • Phase 2
    NuGel
    Atopic Dermatitis (Atopic Eczema) Hudson Therapeutics Inc
  • Phase 2
← prev
page 21 of 53
next →
131
Pain89
Neurology1
OA-SYS
Osteoarthritis
Ageless Biotech Inc
  • Phase 2
    OATD-01
    Pulmonary Sarcoidosis Molecure SA
  • Phase 2
    OBI-902
    Bile Duct Cancer (Cholangiocarcinoma) OBI Pharma Inc
  • Phase 2
    OBX-115
    Metastatic Melanoma Obsidian Therapeutics Inc
  • Phase 2
    OCU-410
    Geographic Atrophy$OCGN Ocugen, Inc.
  • Phase 2
    OLX-101A
    Hypertrophic Scars OliX Pharmaceuticals Inc
  • Phase 2
    OMO-1
    Solid Tumor DeuterOncology NV
  • Phase 2
    ONC-841
    Colorectal Cancer OncoC4 Inc
  • Phase 2
    ONO-2020
    Alzheimer's Disease Ono Pharmaceutical Co Ltd
  • Phase 2
    ONO-2808
    Multiple System Atrophy (Multi-System Degeneration) Ono Pharmaceutical Co Ltd
  • Phase 2
    OPC-1
    Acute Spinal Cord Injury$LCTX Lineage Cell Therapeutics, Inc.
  • Phase 2
    OPCT-001
    Retinal Degeneration BlueRock Therapeutics LP
  • Phase 2
    OPF-310
    Type 1 Diabetes (Juvenile Diabetes) Otsuka Pharmaceutical Co Ltd
  • Phase 2
    OPGx-BEST1
    Macular Degeneration$IRD Opus Genetics, Inc.
  • Phase 2
    ORKA-001
    Plaque Psoriasis (Psoriasis Vulgaris)$ORKA Oruka Therapeutics, Inc.
  • Phase 2
    ORTHO-R
    Unspecified Musculoskeletal Disorders ChitogenX Inc
  • Phase 2
    ORX-142
    Sleep Disorders$CNTA Centessa Pharmaceuticals plc
  • Phase 2
    OTL-201
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Kyowa Kirin Co Ltd
  • Phase 2
    OXI-4503
    Refractory Acute Myeloid Leukemia$OTLC Oncotelic Therapeutics, Inc.
  • Phase 2
    OpRegen
    OpRegen
    Geographic Atrophy F. Hoffmann-La Roche Ltd
  • Phase 2
    Optiquel
    Optiquel
    Non-infectious Uveitis Enzo Biochem Inc
  • Phase 2
    Oral Psilocybin
    psilocybin
    Substance (Drug) Abuse Revive Therapeutics Ltd
  • Phase 2
    Organ Dysfunction/Mortality
    Unspecified BioAegis Therapeutics Inc
  • Phase 2
    OriCAR-017
    Refractory Multiple Myeloma Oricell Therapeutics (Shanghai) Co Ltd
  • Phase 2
    P-12
    Burns NeoMatrix Therapeutics Inc
  • Phase 2
    P-4M01
    Periodontal Disease P4 Microbiome Inc
  • Phase 2
    PALI-2108
    Ulcerative Colitis$PALI PALISADE BIO, INC.